Bayer Beats Failure-To-Warn Action In Trasylol MDL

Law360, New York (April 3, 2013, 4:02 PM EDT) -- A Florida federal judge on Tuesday pared multidistrict litigation over Bayer Corp.’s blood-clotting drug Trasylol after finding an expert witness had not properly considered all the necessary information in finding that the drug was responsible for a heart transplant patient’s kidney failure and death.

The MDL was consolidated in the Southern District of Florida in 2008 after suits over safety concerns related to the drug, used to stanch bleeding in coronary artery bypass graft surgery, began to pile up across the U.S. The plaintiffs claim that Bayer...
To view the full article, register now.